Revised guidelines for heart health are set to move away from target-based approach.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Change history
08 March 2013
This story originally gave the wrong location of Watertown for Decision Resources. The company is based in Burlington, Massachusetts, and the text has been corrected to reflect this.
Related links
Related links
Related links in Nature Research
Fish Oil Supplement Research Remains Murky 2012-Sep-25
Drug data reveal sneaky side effects 2012-Mar-14
Genomics: Variations in blood lipids 2010-Aug-04
Should healthy people take statins too? 2008-Nov-10
Blogpost: FDA approves antisense cholesterol drug
Blogpost: Epigenetic drug may lower cholesterol build-up
Blogpost: Another drugmaker abandons plans to boost 'good' cholesterol
Related external links
Rights and permissions
About this article
Cite this article
Ledford, H. Cholesterol limits lose their lustre. Nature 494, 410–411 (2013). https://doi.org/10.1038/494410a
Published:
Issue date:
DOI: https://doi.org/10.1038/494410a
This article is cited by
-
Goal-directed treatment of osteoporosis in Europe
Osteoporosis International (2014)
